Atai Life Sciences Operating Income 2020-2024 | ATAI

Atai Life Sciences operating income from 2020 to 2024. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
Atai Life Sciences Annual Operating Income
(Millions of US $)
2024 $-103
2023 $-125
2022 $-145
2021 $-136
2020 $-104
2019 $-18
Atai Life Sciences Quarterly Operating Income
(Millions of US $)
2024-12-31 $-30
2024-09-30 $-23
2024-06-30 $-26
2024-03-31 $-24
2023-12-31 $-34
2023-09-30 $-27
2023-06-30 $-32
2023-03-31 $-33
2022-12-31 $-38
2022-09-30 $-38
2022-06-30 $-35
2022-03-31 $-33
2021-12-31 $-45
2021-09-30 $-33
2021-06-30 $-61
2021-03-31 $4
2020-12-31 $-87
2020-09-30 $-7
2020-06-30 $-6
2020-03-31 $-4
2019-12-31
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.278B $0.000B
atai Life Sciences B.V. is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. atai Life Sciences B.V. is based in BERLIN.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $19.711B 19.42
Encompass Health (EHC) United States $11.842B 25.10
DaVita (DVA) United States $11.065B 14.69
Chemed (CHE) United States $8.448B 26.55
Elanco Animal Health (ELAN) United States $5.962B 12.78
Option Care Health (OPCH) United States $5.476B 24.41
RadNet (RDNT) United States $4.123B 87.25
Amedisys (AMED) United States $3.155B 21.22
LifeStance Health (LFST) United States $2.143B 0.00
Addus HomeCare (ADUS) United States $2.066B 22.68
Astrana Health (ASTH) United States $1.802B 36.11
U.S Physical Therapy (USPH) United States $1.078B 28.61
Pennant (PNTG) United States $0.957B 35.14
Aveanna Healthcare Holdings (AVAH) United States $0.940B 0.00
Daxor (DXR) United States $0.036B 0.00
Ontrak (OTRK) United States $0.006B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.004B 0.00
Psychemedics (PMD) United States $0.000B 0.00